|
1) Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med. 2000; 342: 301-7
|
|
|
|
2) Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003; 26: 2345-52
|
|
|
|
|
|
3) 花房俊昭, 今川彰久, 岩橋博見, 他. 劇症1型糖尿病調査研究委員会報告—疫学調査の解析と診断基準の策定. 糖尿病. 2005; 48 Suppl 1: A1-13
|
|
|
|
|
|
4) Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab. 2007; 3: 36-45
|
|
|
|
|
|
5) Murao S, Makino H, Kaino Y, et al. Differences in the contribution of HLA-DR and -DQ haplo-types to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. Diabetes. 2004; 53: 2684-90
|
|
|
|
|
|
6) Cho YM, Kim JT, Ko KS, et al. Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia. 2007; 50: 2276-9
|
|
|
|
|
|
7) Imagawa A, Hanafusa T, Uchigata Y, et al. Different contribution of class II HLA in ful-minant and typical autoimmune type 1 diabetes mellitus. Diabetologia. 2005; 48: 294-300
|
|
|
|
|
|
8) Kawasaki E, Imagawa A, Makino H, et al. Differences in the contribution of CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care. 2008; 31: 1608-10
|
|
|
|
|
|
9) 花房俊昭, 今川彰久, 岩橋博見, 他. 劇症1型糖尿病調査研究委員会報告(追補)—発症時のウイルス抗体価について. 糖尿病. 2008; 51: 531-6
|
|
|
|
|
|
10) Tanaka S, Kobayashi T, Momotsu T. A novel subtype of type 1 diabetes mellitus. N Engl J Med. 2000; 342: 1835-8 (Correspondence)
|
|
|
|
|
|
11) Shibasaki S, Imagawa A, Iino M, et al. Mono-nuclear cell infiltration to both encocrine and exocrine pancreas in patients with fulminant type 1 diabetes just after the onset. Acta Diabetologia. 2007; 44 Suppl 1: S47
|
|
|
|
|
|
12) Katsumata K, Katsumata K. A Chinese patient presenting with clinical signs of fulminant type 1 diabetes mellitus. Intern Med. 2005; 44: 967-9
|
|
|
|
|
13) Chiou CC, Chung WH, Hung SI, et al. Fulminant type 1 diabetes mellitus caused by drug hyper-sensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol. 2006; 54: S14-7
|
|
|
|
|
|
14) Wang T, Xiao XH, Li WH, et al. Fulminant type 1 diabetes: report of two cases. Chin Med J (Engl). 2008; 121: 181-2
|
|
|
|
|
|
15) Pozzilli P, Visalli N, Leslie D, et al. No evidence of rapid onset (Japanese) Type I diabetes in Caucasian patients. Diabetologia. 2000; 43: 1332
|
|
|
|
|
|
16) Balasubramanian K, Dabadghao P, Bhatia V, et al. High frequency of type 1B (idiopathic) diabetes in north Indian children with recent-onset diabetes. Diabetes Care. 2003; 26: 2697
|
|
|
|
|
|
17) Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immuno-genetic andβ-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab. 2003; 88: 5090-8
|
|
|
|
|
|
18) Shimizu I, Makino H, Imagawa A, et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab. 2006; 91: 471-6
|
|
|
|
|
|
19) Imagawa A, Hanafusa T, Makino H, et al. High titres of IgA antibodies to enterovirus in fulmi-nant type-1 diabetes. Diabetologia. 2005; 48: 290-3
|
|
|
|
|
|
20) Sekine N, Motokura T, Oki T, et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hyper-sensitivity syndrome. JAMA. 2001; 285: 1153-4
|
|
|
|
|
|
21) 太田一樹, 高元俊彦, 和泉宏幸, 他. 薬疹(hypersensitivity syndrome)に対するステロイド投与中に発症した劇症1型糖尿病の1例. 糖尿病. 2001; 44: 907-12
|
|
|
|
|
|
22) 山本繁樹, 藤本裕司, 平川乃理子, 他. Hyper-sensitivity syndromeを契機に発症した劇症1型糖尿病の1例. 糖尿病. 2003; 46: 949-54
|
|
|
|
|
|
23) Seino Y, Yamauchi M, Hirai C, et al. A case of fulminant type 1 diabetes associated with mexiletine hypersensitivity syndrome. Diabet Med. 2004; 21: 1156-7
|
|
|
|
|
|
24) 長岡 匡, 寺田光宏, 宮腰久嗣. 急性膵炎発症後急速にインスリン依存状態をきたし, 単純ヘルペスウイルスの関与が考えられた糖尿病の1例. 糖尿病. 2001; 44: 335-40
|
|
|
|
|
|
25) 西田 亙, 長谷部晋二, 川村良一, 他. 発症時コクサッキーウィルスB3中和抗体価の上昇がみられた劇症1型糖尿病の1例. 糖尿病. 2005; 48 Suppl 1: A23-7
|
|
|
|
|
|
26) 赤塚 元, 末松三奈, 松本和隆, 他. コクサッキーウイルスB4が発症に関与したと推測された劇症1型糖尿病の1例. 糖尿病. 2007; 50: 637
|
|
|
|
|
|
27) 藤谷 淳, 傍島裕司, 青木孝彦, 他. 多発性骨髄腫の経過中Epstein-Barr virus(EBV)感染を契機に発症した劇症1型糖尿病の1例. 糖尿病. 2007; 50: 638
|
|
|
|
|
|
28) Sano H, Terasaki J, Tsutsumi C, et al. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res Clin Pract. 2008; 79: e8-9
|
|
|
|
|
|
29) Goto A, Takahashi Y, Kishimoto M, et al. A case of fulminant type 1 diabetes associated with significant elevation of mumps titers. Endocr J. 2008; 55: 561-4
|
|
|
|
|
30) Kano Y, Hiraharas K, Sakuma K, et al. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol. 2006; 155: 301-6
|
|
|
|
|
|
31) Sayama K, Imagawa A, Okita K, et al. Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment. Diabetologia. 2005; 48: 1560-4
|
|
|
|
|
|
32) Moriwaki M, Itoh N, Miyagawa J, et al. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus. Diabetologia. 1999; 42: 1332-40
|
|
|
|
|